Q32 Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Q32 Bio (QTTB).

Price Target Range — 8 Quarters

Analyst Consensus — 12 Analysts

9Buy

3Hold

Consensus RatingOutperform# Analysts12Avg. Consensus PT$33Upside to Avg. PT+281.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	Leerink Partners	Will Soghikian	Initiate	Outperform	$40
Sep 28, 2026	Jefferies	Maury Raycroft	Initiate	Buy	$29
Aug 24, 2026	Morgan Stanley	Judah Frommer	Initiate	Overweight	$34
Jul 28, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$13→$36
Jul 13, 2026	Wells Fargo	Derek Archila	Upgrade	Equal-Weight→Overweight	$66
Jul 13, 2026	Oppenheimer	Jay Olson	PT Raise	Outperform	$20→$40
May 22, 2026	Mizuho	Joseph Catanzaro	Initiate	Outperform	$14
May 18, 2026	Cantor Fitzgerald	—	Initiate	Overweight	—
May 5, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$13
Feb 25, 2026	HC Wainwright & Co.	Joseph Pantginis	Initiate	Buy	$13
Mar 12, 2025	Wells Fargo	Derek Archila	PT Cut	Equal-Weight	$16→$15
Feb 11, 2025	BMO Capital	Etzer Darout	Downgrade	Outperform→Market Perform	$22→$3
Feb 11, 2025	Piper Sandler	Christopher Raymond	Downgrade	Overweight→Neutral	$20→$4
Dec 12, 2024	BMO Capital	Etzer Darout	PT Cut	Outperform	$64→$22
Dec 12, 2024	Guggenheim	Yatin Suneja	Downgrade	Buy→Neutral	—
Dec 11, 2024	Oppenheimer	Jay Olson	PT Cut	Outperform	$80→$20
Dec 11, 2024	Piper Sandler	Christopher Raymond	PT Cut	Overweight	$85→$20
Dec 11, 2024	Wells Fargo	Derek Archila	Downgrade	Overweight→Equal-Weight	$95→$16
Dec 11, 2024	Leerink Partners	Thomas Smith	Downgrade	Outperform→Market Perform	$68→$9
Dec 11, 2024	Raymond James	Steven Seedhouse	Downgrade	Strong Buy→Outperform	$90→$22

Analyst Ratings News

PRO
Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

Leerink Partners analyst Will Soghikian initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Outperform rating and announces Price Target of $40.

Benzinga Newsdesk

PRO
Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

Jefferies analyst Maury Raycroft initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $29.

Benzinga Newsdesk

PRO
Morgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

Morgan Stanley analyst Judah Frommer initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Overweight rating and announces Price Target of $34.

Benzinga Newsdesk

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on top names. For a complete view, see analyst ratings page. See how others view these stocks.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

HC Wainwright & Co. analyst Joseph Pantginis maintains Q32 Bio (NASDAQ:QTTB) with a Buy and raises the price target from $13 to $36.

Benzinga Newsdesk

PRO
Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

Wells Fargo analyst Derek Archila upgrades Q32 Bio (NASDAQ:QTTB) from Equal-Weight to Overweight and announces $66 price target.

Benzinga Newsdesk

Q32 Bio Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Q32 Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

PRO
Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

PRO
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

PRO
Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

People Also Watch

People Also Watch

Q32 Bio Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Q32 Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLeerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

PROJefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

PROMorgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

PROHC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

PROWells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

People Also Watch

People Also Watch

PRO
Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

PRO
Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

PRO
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

PRO
Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target